Back to today’s briefing

Story perspectives

FDA Approves At-Home STD Test Amid Infection Surge

1/12/2026

50 6

Summary

Story summary

The U.S. FDA approved a three-in-one at-home test for gonorrhea, chlamydia, and trichomoniasis to help curb infections.
The FDA approved two new oral drugs for gonorrhea.
The rise in infections during the COVID-19 pandemic provides context for expanded testing.
Experts caution that high test costs and funding cuts to public health agencies could limit access, even as testing options expand.

1 of 1

Story summary

The U.S. FDA approved a three-in-one at-home test for gonorrhea, chlamydia, and trichomoniasis to help curb infections.
The FDA approved two new oral drugs for gonorrhea.
The rise in infections during the COVID-19 pandemic provides context for expanded testing.
Experts caution that high test costs and funding cuts to public health agencies could limit access, even as testing options expand.